Clinical Validation of Fasd (Venesection) in the management of Khafqan (Palpitations): A Randomized open label study with standard control
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- ECG
研究概览
简要总结
Khafqan or palpitation is haracterized by an awareness of the beating of the heart.Patients commonly describe pounding or fluttering heart beats or reports a sensation that the heart is stopping or skipping beats.In unani system of medicine heart is one of the three fundamental organs of the body.Heart is considered as the cheif of vital organs and palpitation is described as critical for heart ailments.Avicenna in his renowed book Cnon of medicine has mentioned palpitation as follows: Palpitation is an irregular mvement of heart.This may be caused by heart utself, pericardium, neighbouring or associated organs.It ocurs due to humoral deragement, simple morbid temperament, inflammatory conditions, dissolution, extrinsic factors or hypersentivity.
Moderm management first line therapy for symptomatic palpitations is beta blocker or calcium channel blocker.Patients who are refractory to medical therapy or who develop left ventricular dysfunction should undergo catheter ablation of premature ventricular contractions.However there are number of drugs and regimens in unani system of medicine for khafqan which are safe and effective.Unani management includes evacuation if is caused by predominance of humous.Evacuation id done through emesis and purgation if it is caused by gastric involvement.In this respect A study entitled Clinical validation of Fasd (Venesection) in the management of Khafqan (Palpitations): A randamized open labelled study with standard control study has been designed.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)(—)
- 性别
- All
入选标准
- •Clinically diagnosed patients of Khafqan (Palpitations) Patients in age group of 18 to 65 irrespective of gender Patients who are ready to sign the informed consent, follow the protocol and willing to participate in clinical study voluntarily.
排除标准
- •Known cases of Arrhythmias and any bleeding disorders (Thalassemia Hemophilia Menorrhagia or any blood-dyscrasias) Moderate to Severe Anemic patients Viral Infections like STDs (AIDS Hepatitis B & C) Known case of uncontrolled Diabetes Mellitus & HTN Patients below 18 years and above 65 years History of substance abuse: Caffeine Alcohol Drug intoxication Patient who fails to followup Patient who fails to give writtenconsent Known cases of Hyperthyroidism Cardiovascular diseass Renal disease and Liver disease Pregnant and lactating mother.
结局指标
主要结局
ECG
时间窗: 60days
VAS (Visual Analogue Scale)
时间窗: 60days
次要结局
- tachycardia(Hypertension)
研究者
Dr Mohammed Sheeraz Mushtaque Ahmed
Regional Research Institute of Unani Medicine,Habbak Srinagar
